Cipla Limited and Boehringer Ingelheim India Pvt. Ltd. have announced their partnership in India to co-market three new oral anti-diabetics drugs Oboravo® (Empagliflozin), Oboravo Met® (Empagliflozin+Metformin) and Tiptengio® (Empagliflozin+Linagliptin) As per the International Diabetes Federation, India is home to 77 million adults aged between 20 and 79 years with diabetes, ranking second behind China; and is poised to reach 134.2 million patients by 2045. Fortunately, … Continue reading Three new oral anti-diabetics drugs in India- co-marketed by Cipla & Boehringer Ingelheim

Covid 19 infected Patients suffering from severe respiratory symptoms can rapidly generate an immune response in the form of virus-attacking T cells, suggests a new study which may lead to new vaccine development strategies against COVID-19. The study, published in the journal Science Immunology, assessed T cells from 10 COVID-19 patients under intensive care treatment. According to the researchers, including those from the University of … Continue reading Identified Immune Response Protection Against COVID-19

The approval of ‘COVIFOR’, the generic of Remdesivir by Drugs Controller General of India (DCGI), Hetero Healthcare Limited, a group company of Hetero is set to deliver the first set of 20,000 vials in two equal lots of 10,000 each, one of which, will be immediately supplied to Hyderabad, Delhi, Gujarat, Tamil Nadu, Mumbai and other parts of Maharashtra; while the other lot will be supplied to … Continue reading Covifor is the first generic brand of Remdesivir

National Institute of Immunology (NII), New Delhi’s scientists found that substitution of the helix with a flexible peptide sequence in the full-length hGBP-1 (termed as linker protein) effective in GMP formation. Unlike wild-type, the linker protein is not capable of undergoing substrate-induced oligomerization, suggesting the importance of the helix in oligomerization during the GTP hydrolysis. Furthermore, they examined the effect of interactions between this helix … Continue reading National Institute of Immunology found substitution of α-helix with a flexible peptide as linker protein for enhanced GMP formation

The fight against Chikungunya disease has got a major boost with CEPI, the global Coalition for Epidemic Preparedness Innovations, and its Indian arm Ind-CEPI, announcing a new partnering agreement with a consortium comprising Hyderabad based Bharat Biotech (BBIL) and the International Vaccine Institute (IVI) to promote the development of a vaccine against the disease. CEPI will fund the consortium with up to US $14.1 million … Continue reading R&D boost to a vaccine against Chikungunya-Bharat Biotech

CSIR’s constituent lab, Institute of Genomics and Integrative Biology (CSIR-IGIB) and TATA Sons signed a MoU for licensing of KNOWHOW for FNCAS9 EDITOR LINKED UNIFORM DETECTION ASSAY (FELUDA) FOR RAPID DIAGNOSIS OF COVID-19. The license shall include transfer of the knowledge for scaling up the KNOWHOW in the form of a kit that can be deployed for COVID-19 testing on ground as early as end … Continue reading CSIR Lab “IGIB” and TATA Sons sign an MoU for development of a kit for rapid and accurate diagnosis of COVID-19

It will decide the future course of action against the pandemic, ICMR has communicated a detailed plan to all the states to measure coronavirus exposure in general population as well as in high risk populations. This sero-survey will guide appropriate public health intervention. An indicative list of different groups has been provided for adequate representation . The numbers and frequency in different groups to be tested … Continue reading Indian Council of Medical Research advises for conduct sero-survey to measure Coronavirus exposure in the population using IgG ELISA Test

Prime Minister of India Shri Narendra Modi and the Hon Scott Morrison MP, Prime Minister of Australia jointly announced a Special COVID-19 Collaboration in 2020 during an India-Australia Leaders’ Virtual Summit on 04 June 2020. Accordingly, Department of Science & Technology (DST), Ministry of Science & Technology, GOI and Department of Industry, Science, Energy and Resources (DISER), Australia have invited joint research projects on COVID-19 … Continue reading DST india- invited Research proposals for COVID-19 for bilateral collaboration in science between India & Australia